{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T09:02:51Z","timestamp":1776934971335,"version":"3.51.2"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T00:00:00Z","timestamp":1205971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T00:00:00Z","timestamp":1205971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s00428-008-0586-9","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T10:28:41Z","timestamp":1205922521000},"page":"651-665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Replacement of \u03b1-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients"],"prefix":"10.1007","volume":"452","author":[{"given":"Jana","family":"Keslov\u00e1-Vesel\u00edkov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"H\u016flkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Dobrovoln\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Befekadu","family":"Asfaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Poup\u011btov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Bern\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubor","family":"Gol\u00e1\u0148","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Ledvinov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Elleder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,20]]},"reference":[{"key":"586_CR1","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1126\/science.275.5302.964","volume":"275","author":"T Asahara","year":"1997","unstructured":"Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964\u2013967","journal-title":"Science"},{"key":"586_CR2","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1194\/jlr.M100423-JLR200","volume":"43","author":"B Asfaw","year":"2002","unstructured":"Asfaw B, Ledvinova J, Dobrovolny R, Bakker HD, Desnick RJ, Van Diggelen OP, De Jong JG, Kanzaki T, Chabas A, Maire I, Conzelmann E, Schindler D (2002) Defects in degradation of blood group A and B glycosphingolipids in Schindler and Fabry diseases. J Lipid Res 43:1096\u20131104","journal-title":"J Lipid Res"},{"key":"586_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1086\/345309","volume":"72","author":"D Blom","year":"2003","unstructured":"Blom D, Speijer D, Linthorst GE, Donker-Koopman WG, Strijland A, Aerts JM (2003) Recombinant enzyme therapy for Fabry disease: absence of editing of human alpha-galactosidase A mRNA. Am J Hum Genet 72:23\u201331","journal-title":"Am J Hum Genet"},{"key":"586_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","volume":"224","author":"S Bolte","year":"2006","unstructured":"Bolte S, Cordelieres FP (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224:213\u2013232","journal-title":"J Microsc"},{"key":"586_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0741-5214(00)70080-2","volume":"31","author":"M Boyer","year":"2000","unstructured":"Boyer M, Townsend LE, Vogel LM, Falk J, Reitz-Vick D, Trevor KT, Villalba M, Bendick PJ, Glover JL (2000) Isolation of endothelial cells and their progenitor cells from human peripheral blood. J Vasc Surg 31:181\u2013189","journal-title":"J Vasc Surg"},{"key":"586_CR6","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1001\/jama.284.21.2771","volume":"284","author":"RO Brady","year":"2000","unstructured":"Brady RO, Schiffmann R (2000) Clinical features of and recent advances in therapy for Fabry disease. JAMA 284:2771\u20132775","journal-title":"JAMA"},{"key":"586_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00041552-200403000-00012","volume":"13","author":"BM Brenner","year":"2004","unstructured":"Brenner BM, Grunfeld JP (2004) Renoprotection by enzyme replacement therapy. Curr Opin Nephrol Hypertens 13:231\u2013241","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"586_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.cub.2005.01.049","volume":"15","author":"NA Bright","year":"2005","unstructured":"Bright NA, Gratian MJ, Luzio JP (2005) Endocytic delivery to lysosomes mediated by concurrent fusion and kissing events in living cells. Curr Biol 15:360\u2013365","journal-title":"Curr Biol"},{"key":"586_CR9","first-page":"3733","volume-title":"The metabolic and molecular bases of inherited disease","author":"R Desnick","year":"2001","unstructured":"Desnick R, Ioannou YA, Eng CM (2001) Alpha-galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, VAlle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3733\u20133774"},{"key":"586_CR10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","volume":"83","author":"R Dobrovolny","year":"2005","unstructured":"Dobrovolny R, Dvorakova L, Ledvinova J, Magage S, Bultas J, Lubanda JC, Elleder M, Karetova D, Pavlikova M, Hrebicek M (2005) Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population. J Mol Med 83:647\u2013654","journal-title":"J Mol Med"},{"key":"586_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/08035320310000465","volume":"92","author":"M Elleder","year":"2003","unstructured":"Elleder M (2003) Sequelae of storage in Fabry disease\u2014pathology and comparison with other lysosomal storage diseases. Acta Paediatr Suppl 92:46\u201353 discussion 45","journal-title":"Acta Paediatr Suppl"},{"key":"586_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1086\/318809","volume":"68","author":"CM Eng","year":"2001","unstructured":"Eng CM, Banikazemi M, Gordon RE, Goldman M, Phelps R, Kim L, Gass A, Winston J, Dikman S, Fallon JT, Brodie S, Stacy CB, Mehta D, Parsons R, Norton K, O, Callaghan M, Desnick RJ (2001a) A phase 1\/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance, and safety studies. Am J Hum Genet 68:711\u2013722","journal-title":"Am J Hum Genet"},{"key":"586_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ (2001b) Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry\u2019s disease. N Engl J Med 345:9\u201316","journal-title":"N Engl J Med"},{"key":"586_CR14","unstructured":"Genzyme, Corporation (2001) Product Monograph, Enzyme replacement therapy for Fabry disease"},{"key":"586_CR15","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1681\/ASN.2006080816","volume":"18","author":"DP Germain","year":"2007","unstructured":"Germain DP, Waldek S, Banikazemi M, Bushinsky DA, Charrow J, Desnick RJ, Lee P, Loew T, Vedder AC, Abichandani R, Wilcox WR, Guffon N (2007) Sustained, long-term renal stabilization after 54\u00a0months of agalsidase beta therapy in patients with Fabry disease. J Am Soc Nephrol 18:1547\u20131557","journal-title":"J Am Soc Nephrol"},{"key":"586_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/0003-2697(72)90094-2","volume":"48","author":"EF Hartree","year":"1972","unstructured":"Hartree EF (1972) Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 48:422\u2013427","journal-title":"Anal Biochem"},{"key":"586_CR17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/000313480006600407","volume":"66","author":"DA Hernandez","year":"2000","unstructured":"Hernandez DA, Townsend LE, Uzieblo MR, Haan ME, Callahan RE, Bendick PJ, Glover JL (2000) Human endothelial cell cultures from progenitor cells obtained by leukapheresis. Am Surg 66:355\u2013358 discussion 359","journal-title":"Am Surg"},{"key":"586_CR18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-4157(95)00004-B","volume":"1241","author":"A Hille-Rehfeld","year":"1995","unstructured":"Hille-Rehfeld A (1995) Mannose 6-phosphate receptors in sorting and transport of lysosomal enzymes. Biochim Biophys Acta 1241:177\u2013194","journal-title":"Biochim Biophys Acta"},{"key":"586_CR19","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1517\/14728222.11.6.821","volume":"11","author":"CE Hollak","year":"2007","unstructured":"Hollak CE, Vedder AC, Linthorst GE, Aerts JM (2007) Novel therapeutic targets for the treatment of Fabry disease. Expert Opin Ther Targets 11:821\u2013833","journal-title":"Expert Opin Ther Targets"},{"key":"586_CR20","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1681\/ASN.2006080822","volume":"18","author":"EI Christensen","year":"2007","unstructured":"Christensen EI, Zhou Q, Sorensen SS, Rasmussen AK, Jacobsen C, Feldt-Rasmussen U, Nielsen R (2007) Distribution of alpha-galactosidase A in normal human kidney and renal accumulation and distribution of recombinant alpha-galactosidase A in Fabry mice. J Am Soc Nephrol 18:698\u2013706","journal-title":"J Am Soc Nephrol"},{"key":"586_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1086\/316953","volume":"68","author":"YA Ioannou","year":"2001","unstructured":"Ioannou YA, Zeidner KM, Gordon RE, Desnick RJ (2001) Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice. Am J Hum Genet 68:14\u201325","journal-title":"Am J Hum Genet"},{"key":"586_CR22","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/j.bbamem.2006.05.027","volume":"1758","author":"T Kolter","year":"2006","unstructured":"Kolter T, Sandhoff K (2006) Sphingolipid metabolism diseases. Biochim Biophys Acta 1758:2057\u20132079","journal-title":"Biochim Biophys Acta"},{"key":"586_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/glycob\/cwg034","volume":"13","author":"K Lee","year":"2003","unstructured":"Lee K, Jin X, Zhang K, Copertino L, Andrews L, Baker-Malcolm J, Geagan L, Qiu H, Seiger K, Barngrover D, McPherson JM, Edmunds T (2003) A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease. Glycobiology 13:305\u2013313","journal-title":"Glycobiology"},{"key":"586_CR24","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-67234-7","volume-title":"Enzyme histochemistry. A laboratory manual","author":"Z Lojda","year":"1979","unstructured":"Lojda Z, Gossrau R, Schiebler TH (1979) Enzyme histochemistry. A laboratory manual. Springer, Berlin"},{"key":"586_CR25","doi-asserted-by":"crossref","unstructured":"Luzio JP, Pryor PR, Gray SR, Gratian MJ, Piper RC, Bright NA (2005) Membrane traffic to and from lysosomes. Biochemical Society Symposium, pp 77\u201386","DOI":"10.1042\/bss0720077"},{"key":"586_CR26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2818.1993.tb03313.x","volume":"169","author":"EMM Manders","year":"1993","unstructured":"Manders EMM, Verbeek FJ, Aten JA (1993) Measurement of colocalization of objects in dual-color confocal images. J Microsc\u2013Oxford 169:375\u2013382","journal-title":"J Microsc\u2013Oxford"},{"key":"586_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0009-8981(81)90384-3","volume":"112","author":"JS Mayes","year":"1981","unstructured":"Mayes JS, Scheerer JB, Sifers RN, Donaldson ML (1981) Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry\u2019s disease. Clin Chim Acta 112:247\u2013251","journal-title":"Clin Chim Acta"},{"key":"586_CR28","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1073\/pnas.87.9.3493","volume":"87","author":"S Morimoto","year":"1990","unstructured":"Morimoto S, Yamamoto Y, O, Brien JS, Kishimoto Y (1990) Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases. Proc Natl Acad Sci U S A 87:3493\u20133497","journal-title":"Proc Natl Acad Sci U S A"},{"key":"586_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ymgme.2006.11.008","volume":"90","author":"GJ Murray","year":"2007","unstructured":"Murray GJ, Anver MR, Kennedy MA, Quirk JM, Schiffmann R (2007) Cellular and tissue distribution of intravenously administered agalsidase alfa. Mol Genet Metab 90:307\u2013312","journal-title":"Mol Genet Metab"},{"key":"586_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, Yoshida A, Kuriyama M, Hayashibe H, Sakuraba H et al (1995) An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy. N Engl J Med 333:288\u2013293","journal-title":"N Engl J Med"},{"key":"586_CR31","unstructured":"Rasband WS (1997\u20132006). \u201cImageJ\u201d, from http:\/\/rsb.info.nih.gov\/ij\/"},{"key":"586_CR32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1442-9071.2006.01318.x","volume":"34","author":"PA Rozenfeld","year":"2006","unstructured":"Rozenfeld PA, Croxatto O, Ebner R, Fossati CA (2006) Immunofluorescence detection of globotriaosylceramide deposits in conjunctival biopsies of Fabry disease patients. Clin Exp Ophthalmol 34:689\u2013694","journal-title":"Clin Exp Ophthalmol"},{"key":"586_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s10038-005-0342-9","volume":"51","author":"H Sakuraba","year":"2006","unstructured":"Sakuraba H, Murata-Ohsawa M, Kawashima I, Tajima Y, Kotani M, Ohshima T, Chiba Y, Takashiba M, Jigami Y, Fukushige T, Kanzaki T, Itoh K (2006) Comparison of the effects of agalsidase alfa and agalsidase beta on cultured human Fabry fibroblasts and Fabry mice. J Hum Genet 51:180\u2013188","journal-title":"J Hum Genet"},{"key":"586_CR34","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2005.12.006","volume":"27","author":"SS Seehafer","year":"2006","unstructured":"Seehafer SS, Pearce DA (2006) You say lipofuscin, we say ceroid: defining autofluorescent storage material. Neurobiol Aging 27:576\u2013588","journal-title":"Neurobiol Aging"},{"key":"586_CR35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1073\/pnas.97.1.365","volume":"97","author":"R Schiffmann","year":"2000","unstructured":"Schiffmann R, Murray GJ, Treco D, Daniel P, Sellos-Moura M, Myers M, Quirk JM, Zirzow GC, Borowski M, Loveday K, Anderson T, Gillespie F, Oliver KL, Jeffries NO, Doo E, Liang TJ, Kreps C, Gunter K, Frei K, Crutchfield K, Selden RF, Brady RO (2000) Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci U S A 97:365\u2013370","journal-title":"Proc Natl Acad Sci U S A"},{"key":"586_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00428-005-0089-x","volume":"448","author":"R Schiffmann","year":"2006","unstructured":"Schiffmann R, Rapkiewicz A, Abu-Asab M, Ries M, Askari H, Tsokos M, Quezado M (2006) Pathological findings in a patient with Fabry disease who died after 2.5\u00a0years of enzyme replacement. Virchows Arch 448:337\u2013343","journal-title":"Virchows Arch"},{"key":"586_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/jemt.10086","volume":"57","author":"M Simionescu","year":"2002","unstructured":"Simionescu M, Gafencu A, Antohe F (2002) Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. Microsc Res Tech 57:269\u2013288","journal-title":"Microsc Res Tech"},{"key":"586_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1046\/j.1523-1755.2002.0610s1052.x","volume":"61","author":"AS Stern","year":"2002","unstructured":"Stern AS, Klotman ME, Ioannou YA, Burrow CR, Wilson PD, Klotman PE, Lipkowitz MS (2002) Polarity of alpha-galactosidase A uptake by renal tubule cells. Kidney Int 61:52\u201355","journal-title":"Kidney Int"},{"key":"586_CR39","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/j.0022-202X.2004.22425.x","volume":"122","author":"BL Thurberg","year":"2004","unstructured":"Thurberg BL, Randolph Byers H, Granter SR, Phelps RG, Gordon RE, O, Callaghan M (2004) Monitoring the 3-year efficacy of enzyme replacement therapy in Fabry disease by repeated skin biopsies. J Invest Dermatol 122:900\u2013908","journal-title":"J Invest Dermatol"},{"key":"586_CR40","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","volume":"62","author":"BL Thurberg","year":"2002","unstructured":"Thurberg BL, Rennke H, Colvin RB, Dikman S, Gordon RE, Collins AB, Desnick RJ, O, Callaghan M (2002) Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int 62:1933\u20131946","journal-title":"Kidney Int"},{"key":"586_CR41","unstructured":"TKT, Europe (2001) Information Brochure, Enzyme replacement therapies for Fabry disease."},{"key":"586_CR42","first-page":"723","volume":"23","author":"J Wenk","year":"1991","unstructured":"Wenk J, Hille A, von Figura K (1991) Quantitation of Mr 46000 and Mr 300000 mannose 6-phosphate receptors in human cells and tissues. Biochem Int 23:723\u2013731","journal-title":"Biochem Int"},{"key":"586_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1086\/422366","volume":"75","author":"WR Wilcox","year":"2004","unstructured":"Wilcox WR, Banikazemi M, Guffon N, Waldek S, Lee P, Linthorst GE, Desnick RJ, Germain DP (2004) Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. Am J Hum Genet 75:65\u201374","journal-title":"Am J Hum Genet"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-008-0586-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-008-0586-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-008-0586-9.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-008-0586-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T04:32:18Z","timestamp":1684297938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-008-0586-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,20]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1007\/s00428-008-0586-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,20]]},"assertion":[{"value":"18 June 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}